WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare payment for diagnostic testing. Medicare payment/coverage for telemedicine.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES | — |
| KARINA LYNCH | — |
| ROBERT J MARTINEZ | — |
| GEORGE OLSEN | — |
| JOYCE A ROGERS | — |
Chemicals/Chemical Industry CHM
Matters concerning safety and security at chemical plants.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GEORGE OLSEN | — |
| ANTHONY J RODA | — |
Health Issues HCR
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES | — |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| GEORGE OLSEN | — |
| JOYCE A ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.